Salinomycin inhibits SREBP1 to sensitize ferroptosis and ameliorate sorafenib resistance in clear cell renal cell carcinoma Article

Su, Yu, Liu, Xuan, Wang, Dekun et al. (2025). Salinomycin inhibits SREBP1 to sensitize ferroptosis and ameliorate sorafenib resistance in clear cell renal cell carcinoma . 1872(6), 10.1016/j.bbamcr.2025.119989

cited authors

  • Su, Yu; Liu, Xuan; Wang, Dekun; Li, Gang; Mi, Xue; Zhang, Yuying; Yue, Shijing; Zhang, Zhujun; Shen, Tianyu; Tan, Xiaoyue

sustainable development goals

authors

publication date

  • August 1, 2025

keywords

  • ACTIVATION
  • Biochemistry & Molecular Biology
  • CANCER
  • Cell Biology
  • Clear cell renal cell carcinoma
  • DEATH
  • Ferroptosis resistance
  • IRON
  • Life Sciences & Biomedicine
  • Salinomycin
  • Science & Technology
  • Sorafenib
  • Sterol regulatory element binding protein 1

Digital Object Identifier (DOI)

publisher

  • ELSEVIER

volume

  • 1872

issue

  • 6